Sinocelltech

Sinocelltech, based in Beijing, China, is a biotechnology company. Sinocelltech is a biopharmaceutical company that researches, manufactures and commercialises monoclonal antibodies, recombinant proteins and vaccines. On ClinicalTrials.gov it is the lead sponsor of 8 recruiting or active phase 2 and phase 3 interventional cancer trials (6 in phase 3), testing SCTB41, SCTB35, SCTC21C, SCTB39-1 and SCTB14 in multiple myeloma, non-small-cell lung cancer, diffuse large B-cell lymphoma and follicular lymphoma. The largest, NCT06041061 (A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SCT1000 in Healthy Women Aged 18-45 Years), plans to enrol 18000 participants (actual). Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.

Headquarters

Beijing, CN

Scorecard

All companies

#235of 1245 companies, score 22

phase 3 +12
modalities +2
registry trials +8

0 approved, 4 in phase 3, 0 earlier, 0 targets, 16 registry studies. Formula on the scorecards page.

Type

Biotech

Stage

Public

Website

www.sinocelltech.com

Founded

2002

Products

4

Phase 3not stated (registered as a drug or biological on ClinicalTrials.gov)

SCTB41

SCTB41 is an experimental investigational agent whose form is not stated in the registry from Sinocelltech in phase 3 trials for non-small-cell lung cancer, with its target not yet stated publicly.

Phase 3not stated (registered as a drug or biological on ClinicalTrials.gov)

SCTB35

SCTB35 is an experimental investigational agent whose form is not stated in the registry from Sinocelltech in phase 3 trials for diffuse large B-cell lymphoma and follicular lymphoma, with its target not yet stated publicly.

Phase 3not stated (registered as a drug or biological on ClinicalTrials.gov)

SCTC21C

SCTC21C is an experimental investigational agent whose form is not stated in the registry from Sinocelltech in phase 3 trials for multiple myeloma, with its target not yet stated publicly.

Phase 3not stated (registered as a drug or biological on ClinicalTrials.gov)

SCTB14

SCTB14 is an experimental investigational agent whose form is not stated in the registry from Sinocelltech in phase 3 trials for non-small-cell lung cancer, with its target not yet stated publicly.